1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Side-on view of a devastated male investor laying his head on his laptop keyboard
    Broker Notes

    The CSL share price is at a 6-year low. Should you buy?

    | Bronwyn Allen

    The market's largest ASX 200 healthcare share has lost a fifth of its value since last week.

    Read more »

    A man in a business suit peers through binoculars as two businesswomen stand beside him looking straight ahead at the camera.
    Healthcare Shares

    Forecast: Here's what $20,000 invested in CSL shares could be worth by 2030

    | James Mickleboro

    Let's see what analysts think this beaten down biotech giant could be worth at the end of the decade.

    Read more »

    Concept image of a businessman riding a bull on an upwards arrow.
    Share Market News

    'We're in a bull market, no doubt about it': ASX 200 retail sector leads amid another record high

    | Bronwyn Allen

    Many ASX 200 retail heavyweight shares hit multi-year highs as 'animal spirits' powered the market last week.

    Read more »

    ASX shares Business man marking buy on board and underlining it
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
    Cheap Shares

    3 Australian value stocks to buy when everyone else is selling

    | James Mickleboro

    Analysts think these beaten down shares could be buys.

    Read more »

    A happy couple looking at an iPad.
    Superannuation

    10 most popular ASX shares being bought by self-managed superannuation investors in FY26

    | Bronwyn Allen

    Which ASX stocks are SMSF investors favouring in the new financial year?

    Read more »

    A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
    Healthcare Shares

    Why is everyone talking about CSL shares?

    | Samantha Menzies

    CSL suffered a ‘brutal selloff’ this week.

    Read more »

    A man raises his reading glasses in a look of surprise.
    Cheap Shares

    These cheap ASX 200 shares could rise 25% to 30%

    | James Mickleboro

    These shares could be destined to deliver big returns for investors.

    Read more »

    Business people discussing project on digital tablet.
    Broker Notes

    Buy, hold, sell: BHP, CSL, and NAB shares

    | James Mickleboro

    Let's see what analysts at Morgans are saying about these popular stocks.

    Read more »

    A financial expert or broker looks worried as he checks out a graph showing market volatility.
    Healthcare Shares

    Is the CSL share price dirt cheap after crashing this week?

    | James Mickleboro

    Is this beaten down biotech cheap? Let's find out.

    Read more »

    A young man sits at his desk working on his laptop with a big smile on his face.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's what brokers are recommending as buys this week.

    Read more »

    woman crying while eating ice cream
    Share Fallers

    3 ASX heavyweights stumble on earnings results

    | Leigh Gant

    Three household names on the ASX have taken a hit following their latest results.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note